Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,016,000 | 142,000 | 108,000 | 966,000 | 1,862,000 |
| Cost of Goods | 207,000 | 119,000 | 90,000 | 739,000 | 514,000 |
| Gross Profit | 809,000 | 23,000 | 18,000 | 227,000 | 1,348,000 |
| Operating Expenses | 1,069,000 | 930,000 | 1,068,000 | 1,473,000 | 1,418,000 |
| Operating Income | -260,000 | -907,000 | -1,050,000 | -1,246,000 | -70,000 |
| Other Income | 73,000 | 89,000 | 86,000 | 62,000 | 91,000 |
| Pre-tax Income | -187,000 | -818,000 | -964,000 | -1,184,000 | 21,000 |
| Income Tax | 13,000 | 7,000 | 7,000 | -64,000 | 8,000 |
| Net Income Continuous | -200,000 | -825,000 | -971,000 | -1,120,000 | 13,000 |
| Net Income | $-200,000 | $-825,000 | $-971,000 | $-1,120,000 | $13,000 |
| EPS Basic Total Ops | -0.51 | -2.13 | -2.52 | -2.91 | 0.03 |
| EPS Basic Continuous Ops | -0.51 | -2.13 | -2.52 | -2.90 | 0.03 |
| EPS Diluted Total Ops | -0.51 | -2.13 | -2.52 | -2.91 | 0.03 |
| EPS Diluted Continuous Ops | -0.51 | -2.13 | -2.52 | -2.90 | 0.03 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -2.13 | -2.52 | -2.50 | 0.03 |
| EBITDA(a) | $-225,000 | $-868,000 | $-1,030,000 | $-1,205,000 | $-39,000 |